Table 3.
IgG
|
IgA
|
DNA*
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Cases (n=142) | Controls (n=142) | P-value | Cases (n=142) | Controls (n=142) | P-value | Cases (n=128) | Controls (n=143) | ||
Chlamydia pneumoniae | Samples (%) | 41 (28.9) | 47 (33.1) | 0.521 | 29 (20.4) | 31 (21.8) | 0.885 | 2 (1.6) | 0 (0) |
HSV-1 | Samples (%) | 125 (88.0) | 124 (87.3) | 1.000 | 12 (8.5) | 27 (19.0) | 0.015 | 1 (0.8) | 2 (1.4) |
HHV-6 | Samples (%) | 112 (78.9) | 100 (70.4) | 0.133 | 3 (2.1) | 4 (2.8) | 1.000 | 1 (0.8) | 2 (1.4) |
Toxoplasma gondii | Samples (%) | 56 (39.4) | 29 (20.4) | 0.001 | 1 (0.7) | 2 (1.4) | 0.624 | 1 (0.8) | 0 (0) |
Note:
DNA was scarcely present in samples, so the P-values were not calculated.
Abbreviations: IgA, immunoglobulin A; IgG, immunoglobulin G; HHV, human herpes virus; HSV, herpes simplex virus.